{
"info": {
"nct_id": "NCT02659527",
"official_title": "Randomized Assessment of Patients With Clinically Suspected Prostate Cancer After Multiparametric Metabolic Hybrid Imaging to Evaluate Its Potential Clinical Domain: A Prospective, Randomized, Multi-arm, Multi-treatment Clinical Trial",
"inclusion_criteria": "* blood PSA level > 4.0 ng/ml and\n* free-to-total PSA ratio <22% and/or\n* progressive rise of PSA levels in two consecutive blood samples despite antibiotics\nHealthy volunteers allowed\nMust be MALE",
"exclusion_criteria": "* antiandrogen therapy\n* prostate needle biopsy <21 days before PET/MRI\n* known active secondary cancer\n* endorectal coil not applicable (e.g. anus praetor with short rectal stump)\n* known active prostatitis (e.g. painful DRE)\n* known anaphylaxis against gadolinium-DOTA\n* patient's written informed consent not given\n* needle biopsy and/or prostatectomy compound not available for histology/immunohistochemistry",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* blood PSA level > 4.0 ng/ml and",
"criterions": [
{
"exact_snippets": "blood PSA level > 4.0 ng/ml",
"criterion": "blood PSA level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">",
"value": 4.0,
"unit": "ng/ml"
}
}
]
}
]
},
{
"line": "* free-to-total PSA ratio <22% and/or",
"criterions": [
{
"exact_snippets": "free-to-total PSA ratio <22%",
"criterion": "free-to-total PSA ratio",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": "<",
"value": 22,
"unit": "%"
}
}
]
}
]
},
{
"line": "* progressive rise of PSA levels in two consecutive blood samples despite antibiotics",
"criterions": [
{
"exact_snippets": "progressive rise of PSA levels",
"criterion": "PSA levels",
"requirements": [
{
"requirement_type": "trend",
"expected_value": "progressive rise"
}
]
},
{
"exact_snippets": "two consecutive blood samples",
"criterion": "blood samples",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": ">= 2"
}
]
},
{
"exact_snippets": "despite antibiotics",
"criterion": "antibiotics",
"requirements": [
{
"requirement_type": "effectiveness",
"expected_value": false
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be MALE",
"criterions": [
{
"exact_snippets": "Must be MALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "male"
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* antiandrogen therapy",
"criterions": [
{
"exact_snippets": "antiandrogen therapy",
"criterion": "antiandrogen therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* prostate needle biopsy <21 days before PET/MRI",
"criterions": [
{
"exact_snippets": "prostate needle biopsy <21 days before PET/MRI",
"criterion": "prostate needle biopsy",
"requirements": [
{
"requirement_type": "timing",
"expected_value": {
"operator": "<",
"value": 21,
"unit": "days"
}
}
]
}
]
},
{
"line": "* known active secondary cancer",
"criterions": [
{
"exact_snippets": "known active secondary cancer",
"criterion": "secondary cancer",
"requirements": [
{
"requirement_type": "status",
"expected_value": "active"
},
{
"requirement_type": "knowledge",
"expected_value": true
}
]
}
]
},
{
"line": "* endorectal coil not applicable (e.g. anus praetor with short rectal stump)",
"criterions": [
{
"exact_snippets": "endorectal coil not applicable",
"criterion": "endorectal coil",
"requirements": [
{
"requirement_type": "applicability",
"expected_value": false
}
]
},
{
"exact_snippets": "anus praetor with short rectal stump",
"criterion": "anus praetor",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "anus praetor with short rectal stump",
"criterion": "short rectal stump",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* known active prostatitis (e.g. painful DRE)",
"criterions": [
{
"exact_snippets": "known active prostatitis",
"criterion": "active prostatitis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "painful DRE",
"criterion": "painful DRE",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* known anaphylaxis against gadolinium-DOTA",
"criterions": [
{
"exact_snippets": "known anaphylaxis against gadolinium-DOTA",
"criterion": "anaphylaxis against gadolinium-DOTA",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* patient's written informed consent not given",
"criterions": [
{
"exact_snippets": "patient's written informed consent not given",
"criterion": "written informed consent",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* needle biopsy and/or prostatectomy compound not available for histology/immunohistochemistry",
"criterions": [
{
"exact_snippets": "needle biopsy and/or prostatectomy compound not available for histology/immunohistochemistry",
"criterion": "needle biopsy",
"requirements": [
{
"requirement_type": "availability",
"expected_value": false
}
]
},
{
"exact_snippets": "needle biopsy and/or prostatectomy compound not available for histology/immunohistochemistry",
"criterion": "prostatectomy compound",
"requirements": [
{
"requirement_type": "availability",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}